PMC6581023_01
Plasma glucose during treatment with atezolizumab.
fendo-10-00352-g0001.jpg
PMC6581023_01_fendo-10-00352-g0001.jpg
F1
Her fasting plasma glucose was 85 mg/dL (4.7 mmol/L) before atezolizumab initiation (plasma glucose levels during therapy are shown in Figure 1).